Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001591177 | SCV001817331 | likely benign | not provided | 2020-05-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000520526 | SCV002516810 | likely benign | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001591177 | SCV003917537 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | WWOX: BS1, BS2 |
Gene |
RCV000520526 | SCV000617174 | uncertain significance | not specified | 2017-07-21 | flagged submission | clinical testing | The c.*205_*209delGGGCT variant, located in the 3 prime untranslated region of the WWOX gene, has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. In-silico splice prediction models predict that c.*205_*209delGGGCT does not impact splicing. However, in the absence of RNA/functional studies, the actual effect of the c.*205_*209delGGGCT change in this individual is unknown. The c.*205_*209delGGGCT variant occurs at a region that is not conserved among species. No data are available from control populations to assess the frequency of this variant. We interpret c.*205_*209delGGGCT as a variant of uncertain significance. |